Eric Muriithi Guantai

Eric Muriithi Guantai

Auto-generated profile, based on publicly available information

Eric Muriithi Guantai

Department of Pharmacology, Clinical Pharmacy and Pharmacy Practice, Faculty of Health Sciences, University of Naïrobi, Nairobi, Kenya

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
EGEric M. Guantai
Eric M. Guantai
KNKanyile Ncokazi
Kanyile Ncokazi
TETimothy J. Egan
Timothy J. Egan
JGJiri Gut
Jiri Gut
PRPhilip J. Rosenthal
Philip J. Rosenthal
KCKelly Chibale
Kelly Chibale

1 February 2010 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RHRenate H. Hans
Renate H. Hans
EGEric M. Guantai
Eric M. Guantai
CLCarmen Lategan
Carmen Lategan
PSPeter J. Smith
Peter J. Smith
BWBaojie Wan
Baojie Wan
KCKelly Chibale
Kelly Chibale

18 April 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
EGEric M. Guantai
Eric M. Guantai
KNKanyile Ncokazi
Kanyile Ncokazi
TETimothy J. Egan
Timothy J. Egan
JGJiri Gut
Jiri Gut
PRPhilip J. Rosenthal
Philip J. Rosenthal
KCKelly Chibale
Kelly Chibale

16 November 2015 in ACS Infectious Diseases
Verified
Journal Article
Closed access
PNPeter Mbugua Njogu
Peter Mbugua Njogu
EGEric M. Guantai
Eric M. Guantai
EPElumalai Pavadai
Elumalai Pavadai
KCKelly Chibale
Kelly Chibale

15 March 2011 in Malaria Journal
Verified
Journal Article
Open access
PDF file
EGEric Guantai
Eric Guantai
KCKelly Chibale
Kelly Chibale
Malaria continues to be an enormous global health challenge, with millions of new infections and deaths reported annually. This is partly due to the development of resistance by the malaria parasite to the majority of established anti-malarial drugs, a situation that continues to hamper attempts at controlling the disease. This has spurred intensive drug discovery endeavours geared towards identifying novel, highly active anti-malarial drugs, and the identification of quality leads from natural sources would greatly augment these efforts. The current reality is that other than compounds that have their foundation in historic natural products, there are no other compounds in drug discovery as part of lead optimization projects and preclinical development or further that have originated from a natural product start-point in recent years. This paper briefly presents both classical as well as some more modern, but underutilized, approaches that have been applied outside the field of malaria, and which could be considered in enhancing the potential of natural products to provide or inspire the development of anti-malarial lead compounds.

1 August 2011 in Biochemical Pharmacology
Verified
Journal Article
Closed access
TFTzu-Shean Feng
Tzu-Shean Feng
EGEric M. Guantai
Eric M. Guantai
MNMargo Nell
Margo Nell
CRChristine Jansen van Rensburg
Christine Jansen van Rensburg
KNKanyile Ncokazi
Kanyile Ncokazi
KCKelly Chibale
Kelly Chibale